Improve Drug Efficiacy

Peptinovo’s targeted drug-delivery platform Peptide-Amphiphile Lipid Micelle (PALM™), safely carries stronger doses of proven approved drugs directly into cancer cells while keeping them away from healthy tissue.

Prevent Interaction with Healthy Tissues

Treatment success is improved, nerve damage is avoided, and healthy tissues are protected. Drugs are modified to look like fats and enclosed in the PALM™ nanoparticle for transport in the bloodstream.

Allow Stronger Doses of Chemotherapy

The drug is released after PALM™ is captured by a fat uptake pathway common to cancer cells but not found in nerves or most healthy tissues. PALM™ is adaptable to a wide variety of proven drugs. The first product is a patented derivative of the world-leading chemotherapy drug paclitaxel.

Peptinovo Aims To

  • Improve Drug Efficacy

  • Prevent Interaction with Healthy Tissues

  • Allow Stronger Doses of Chemotherapy

Improve Drug Efficiacy

Peptinovo’s targeted drug-delivery platform Peptide-Amphiphile Lipid Micelle (PALM™), safely carries stronger doses of proven approved drugs directly into cancer cells while keeping them away from healthy tissue.

Prevent Interaction with Healthy Tissues

Treatment success is improved, nerve damage is avoided, and healthy tissues are protected. Drugs are modified to look like fats and enclosed in the PALM™ nanoparticle for transport in the bloodstream.

Allow Stronger Doses of Chemotherapy

The drug is released after PALM™ is captured by a fat uptake pathway common to cancer cells but not found in nerves or most healthy tissues. PALM™ is adaptable to a wide variety of proven drugs. The first product is a patented derivative of the world-leading chemotherapy drug paclitaxel.

Animal Tests Have Been Completed

The technology was successfully validated in animal studies where paclitaxel in PALM™ (PNB-281) outperformed standard

paclitaxel in tumor reduction while avoiding damage to nerves and other healthy tissues.

Animal Tests Have Been Completed

The technology was successfully validated in animal studies where paclitaxel in PALM™ (PNB-281) outperformed standard

paclitaxel in tumor reduction while avoiding damage to nerves and other healthy tissues.

How It Works

  • Cancer Cells Use HDL to Grow

  • PALM™ Looks like HDL to the Cancer Cell

  • Instead of Building Blocks for Cancer Growth –

  • PALM™ Delivers Chemotherapy, Causing Cancer Destruction

Cancer Cells Use HDL to Grow

The patented, innovative PALM™ nanotechnology exploits cancer cells’ dependence on cholesterol for tumor growth, by selectively targeting prodrug forms of potent chemotherapy drugs to the cells’ cholesterol-uptake pathway.

PALM Looks like HDL to the Cancer Cell

PALM™ is designed to be a functional and structural mimic of HDL, the natural, bloodborne carrier of cholesterol to cancer cells. Normally, HDL is captured by a receptor and fat transporter that is abundant on cancer cells.

Instead of Building Blocks for Cancer Growth – PALM™ Delivers Chemotherapy, Causing Cancer Destruction

PALM™ is captured by this same receptor to deliver chemotherapy drugs instead. Cancer cells are destroyed. Most healthy tissues lack this receptor and are spared.

How It Works

  • Cancer Cells Use HDL to Grow

  • PALM™ Looks like HDL to the Cancer Cell

  • Instead of Building Blocks for Cancer Growth –

  • PALM™ Delivers Chemotherapy, Causing Cancer Destruction

Cancer Cells Use HDL to Grow

The patented, innovative PALM™ nanotechnology exploits cancer cells’ dependence on cholesterol for tumor growth, by selectively targeting prodrug forms of potent chemotherapy drugs to the cells’ cholesterol-uptake pathway.

PALM Looks like HDL to the Cancer Cell

PALM™ is designed to be a functional and structural mimic of HDL, the natural, bloodborne carrier of cholesterol to cancer cells. Normally, HDL is captured by a receptor and fat transporter that is abundant on cancer cells.

Instead of Building Blocks for Cancer Growth – PALM™ Delivers Chemotherapy, Causing Cancer Destruction

PALM™ is captured by this same receptor to deliver chemotherapy drugs instead. Cancer cells are destroyed. Most healthy tissues lack this receptor and are spared.

Chemotherapy Drugs are Loaded Into PALM™ as Inactive Prodrugs

Moreover, the chemotherapy drugs are loaded into PALM™ as inactive prodrugs. They do not become active until they are released inside the cancer cell.

Let’s work together to change cancer’s trajectory

We look forward to talking to you. You may contact us for more information.

Enhancing Cancer Survival Rates Through the Development of Intelligent and Targeted Drug Delivery Technologies

Contact Us

Peptinovo Biopharma Inc. 600 S Wagner Road Ann Arbor, Michigan 48103

Follow Us Social Media

Chemotherapy Drugs are Loaded Into PALM™ as Inactive Prodrugs

Moreover, the chemotherapy drugs are loaded into PALM™ as inactive prodrugs. They do not become active until they are released inside the cancer cell.

Let’s work together to change cancer’s trajectory

We look forward to talking to you. You may contact us for more information.

Enhancing Cancer Survival Rates Through the Development of Intelligent and Targeted Drug Delivery Technologies

Follow Us On Social Media

Contact Us

Peptinovo Biopharma Inc. 600 S Wagner Road Ann Arbor, Michigan 48103